Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination

OBJECTIVE: The purpose of this study was to assess the potential immunosuppressive role of daclizumab, a humanized monoclonal antibody against the α chain of the interleukin 2 receptor, in vivo, by comparing immune responses to the 2013 seasonal influenza vaccination between patients with multiple s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yen Chih, Winokur, Paige, Blake, Andrew, Wu, Tianxia, Manischewitz, Jody, King, Lisa R., Romm, Elena, Golding, Hana, Bielekova, Bibiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733151/
https://www.ncbi.nlm.nih.gov/pubmed/26848487
http://dx.doi.org/10.1212/NXI.0000000000000196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733151/
https://www.ncbi.nlm.nih.gov/pubmed/26848487
http://dx.doi.org/10.1212/NXI.0000000000000196

Ejemplares similares